Form 4: Amgen VP, Finance & CAO Matthew C. Busch Reports Stock Transaction
SEC Form 4 Filing
Matthew C. Busch, VP, Finance & CAO of Amgen Inc., reports the disposition of 18 shares of common stock to cover tax obligations.
Summary
- On April 30, 2025, Matthew C. Busch, VP, Finance & CAO of Amgen Inc., reported a transaction involving Amgen's common stock.
- The transaction involved the disposition of 18 shares at a price of $288.56.
- This disposition was likely to cover tax obligations related to the vesting of restricted stock units (RSUs).
- Following the transaction, Busch directly owns 5,099 shares of Amgen common stock, which includes 105 Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock transaction, and does not contain information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of stock transaction |
| 05/01/2025 | Date of signature |
Keywords
Form 4, Amgen, Matthew C. Busch, Stock Transaction, Beneficial Ownership, VP Finance & CAO, AMGN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.